Хайлтын үр дүнгүүд - Sin‐Ho Jung

Үр дүнг сайжруулах
  1. 1
    Sample size for FDR-control in microarray data analysis

    Sample size for FDR-control in microarray data analysis -н Sin‐Ho Jung

    Хэвлэсэн 2005
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  2. 2
    Sample size calculation for multiple testing in microarray data analysis

    Sample size calculation for multiple testing in microarray data analysis -н Sin‐Ho Jung, Heejung Bang, S. Stanley Young

    Хэвлэсэн 2004
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  3. 3
    Photoreceptor Layer Thinning over Drusen in Eyes with Age-Related Macular Degeneration Imaged In Vivo with Spectral-Domain Optical Coherence Tomography

    Photoreceptor Layer Thinning over Drusen in Eyes with Age-Related Macular Degeneration Imaged In Vivo with Spectral-Domain Optical Coherence Tomography -н Stefanie Schuman, Anjum F. Koreishi, Sina Farsiu, Sin‐Ho Jung, Joseph A. Izatt, Cynthia A. Toth

    Хэвлэсэн 2009
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  4. 4
    Randomised, double-blind, placebo-controlled trial of Probiotics To Eliminate COVID-19 Transmission in Exposed Household Contacts (PROTECT-EHC): a clinical trial protocol

    Randomised, double-blind, placebo-controlled trial of Probiotics To Eliminate COVID-19 Transmission in Exposed Household Contacts (PROTECT-EHC): a clinical trial protocol -н Helen Tang, Lauren Bohannon, M. Lew, David Jensen, Sin‐Ho Jung, Aaron T. Zhao, Anthony D. Sung, Paul E. Wischmeyer

    Хэвлэсэн 2021
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  5. 5
    Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsiveness

    Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront... -н M. S. Czuczman, John P. Leonard, Sin‐Ho Jung, Jeffrey L. Johnson, Eric D. Hsi, John C. Byrd, Bruce D. Cheson

    Хэвлэсэн 2012
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  6. 6
    Pemetrexed Plus Cisplatin Versus Gemcitabine Plus Cisplatin According to Thymidylate Synthase Expression in Nonsquamous Non–Small-Cell Lung Cancer: A Biomarker-Stratified Randomized Phase II Trial

    Pemetrexed Plus Cisplatin Versus Gemcitabine Plus Cisplatin According to Thymidylate Synthase Expression in Nonsquamous Non–Small-Cell Lung Cancer: A Biomarker-Stratified Randomize... -н Jong‐Mu Sun, Jin Seok Ahn, Sin‐Ho Jung, Jiyu Sun, Sang Yun Ha, Joungho Han, Keunchil Park, Myung‐Ju Ahn

    Хэвлэсэн 2015
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  7. 7
    Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinoma

    Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinoma -н Jeffrey T. Schleusener, Henry D. Tazelaar, Sin‐Ho Jung, S. Stephen, J. Peter, Jeffrey L. Myers, Edward T. Creagan, Richard M. Goldberg, Robert F. Marschke

    Хэвлэсэн 1996
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  8. 8
    Intensive Chemotherapy and Immunotherapy in Patients With Newly Diagnosed Primary CNS Lymphoma: CALGB 50202 (Alliance 50202)

    Intensive Chemotherapy and Immunotherapy in Patients With Newly Diagnosed Primary CNS Lymphoma: CALGB 50202 (Alliance 50202) -н James L. Rubenstein, Eric D. Hsi, Jeffrey L. Johnson, Sin‐Ho Jung, Megan O. Nakashima, Barbara Grant, Bruce D. Cheson, Lawrence D. Kaplan

    Хэвлэсэн 2013
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  9. 9
    Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B

    Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B -н Won Sohn, Ju‐Yeon Cho, Ji Hoon Kim, Jung Il Lee, Hyung Joon Kim, Min‐Ah Woo, Sin‐Ho Jung, Yong‐Han Paik

    Хэвлэсэн 2017
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  10. 10
    Serious pulmonary toxicity in patients with Hodgkin’s lymphoma with SGN-30, gemcitabine, vinorelbine, and liposomal doxorubicin is associated with an FcγRIIIa-158 V/F polymorphism

    Serious pulmonary toxicity in patients with Hodgkin’s lymphoma with SGN-30, gemcitabine, vinorelbine, and liposomal doxorubicin is associated with an FcγRIIIa-158 V/F polymorphism... -н Kristie A. Blum, Sin‐Ho Jung, Jeffrey L. Johnson, Thomas S. Lin, Eric D. Hsi, David Lucas, John C. Byrd, Bruce D. Cheson, Nancy L. Bartlett

    Хэвлэсэн 2010
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  11. 11
    Randomized Trial of Lenalidomide Alone Versus Lenalidomide Plus Rituximab in Patients With Recurrent Follicular Lymphoma: CALGB 50401 (Alliance)

    Randomized Trial of Lenalidomide Alone Versus Lenalidomide Plus Rituximab in Patients With Recurrent Follicular Lymphoma: CALGB 50401 (Alliance) -н John P. Leonard, Sin‐Ho Jung, Jeffrey L. Johnson, Brandelyn N. Pitcher, Nancy L. Bartlett, Kristie A. Blum, Myron S. Czuczman, Jeffrey K. Giguere, Bruce D. Cheson

    Хэвлэсэн 2015
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  12. 12
    A phase 2 trial of extended induction epratuzumab and rituximab for previously untreated follicular lymphoma: CALGB 50701

    A phase 2 trial of extended induction epratuzumab and rituximab for previously untreated follicular lymphoma: CALGB 50701 -н Barbara Grant, Sin‐Ho Jung, Jeffrey L. Johnson, Lale Kostakoğlu, Eric D. Hsi, John C. Byrd, Jeffrey A. Jones, John P. Leonard, Sabrina Martín, Bruce D. Cheson

    Хэвлэсэн 2013
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  13. 13
    Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study

    Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correl... -н Eric D. Hsi, Sin‐Ho Jung, Raymond Lai, Jeffrey L. Johnson, James R. Cook, Dan Jones, Sven deVos, Bruce D. Cheson, Lloyd E. Damon, Jonathan W. Said

    Хэвлэсэн 2008
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  14. 14
    Clinical relevance of procalcitonin and C-reactive protein as infection markers in renal impairment: a cross-sectional study

    Clinical relevance of procalcitonin and C-reactive protein as infection markers in renal impairment: a cross-sectional study -н Ji Hyeon Park, Do Hee Kim, Hye Ryoun Jang, Min‐Ji Kim, Sin‐Ho Jung, Jung Eun Lee, Wooseong Huh, Yoon-Goo Kim, Dae Joong Kim, Ha Young Oh

    Хэвлэсэн 2014
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  15. 15
    Alveolar Macrophages from Overweight/Obese Subjects with Asthma Demonstrate a Proinflammatory Phenotype

    Alveolar Macrophages from Overweight/Obese Subjects with Asthma Demonstrate a Proinflammatory Phenotype -н Njira Lugogo, John W. Hollingsworth, Druhan L. Howell, Loretta G. Que, Dave Francisco, Tony D. Church, Erin N. Potts-Kant, Jennifer L. Ingram, Ying Wang, Sin‐Ho Jung, Monica Kraft

    Хэвлэсэн 2012
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  16. 16
    Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma

    Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma -н Georgia M. Beasley, Smita K. Nair, Norma E. Farrow, Karenia Landa, Maria Angelica Selim, Carol Ann Wiggs, Sin‐Ho Jung, Darell D. Bigner, Andrea Kelly, Matthias Gromeier, April K.S. Salama

    Хэвлэсэн 2021
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  17. 17
    Interim [<sup>18</sup>F]fluorodeoxyglucose positron emission tomography imaging in stage I–II non-bulky Hodgkin lymphoma: would using combined positron emission tomography and computed tomography criteria better predict response than each test alone?

    Interim [<sup>18</sup>F]fluorodeoxyglucose positron emission tomography imaging in stage I–II non-bulky Hodgkin lymphoma: would using combined positron emission tomography and comp... -н Lale Kostakoğlu, Heiko Schöder, Jeffrey L. Johnson, Nathan C. Hall, Lawrence H. Schwartz, David J. Straus, Ann S. LaCasce, Sin‐Ho Jung, Nancy L. Bartlett, George P. Canellos, Bruce D. Cheson

    Хэвлэсэн 2012
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  18. 18
    CALGB 150905 (Alliance): Rituximab Broadens the Antilymphoma Response by Activating Unlicensed NK Cells

    CALGB 150905 (Alliance): Rituximab Broadens the Antilymphoma Response by Activating Unlicensed NK Cells -н Juan Du, Sandra López‐Vergès, Brandelyn N. Pitcher, Jeffrey L. Johnson, Sin‐Ho Jung, Lili Zhou, Katharine C. Hsu, Myron S. Czuczman, Bruce D. Cheson, Lawrence Kaplan, Lewis L. Lanier, Jeffrey M. Venstrom

    Хэвлэсэн 2014
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  19. 19
    A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin’s lymphoma (NHL): CALGB 50803 (Alliance)

    A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin’s lymphoma (NHL): CALGB 50803 (Alliance) -н Peter W. Martin, Sin‐Ho Jung, Brandelyn N. Pitcher, Nancy L. Bartlett, Kristie A. Blum, M. Tracie Shea, Eric D. Hsi, Jia Ruan, Scott E. Smith, John P. Leonard, Bruce D. Cheson

    Хэвлэсэн 2017
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  20. 20
    Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non–small cell lung cancer

    Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non–small cell lung cancer -н Carolyn E. Reed, David H. Harpole, Katherine E. Posther, Sandra Woolson, Robert J. Downey, Bryan F. Meyers, Robert T. Heelan, Homer A. Macapinlac, Sin‐Ho Jung, Gerard A. Silvestri, Barry A. Siegel, Valerie W. Rusch

    Хэвлэсэн 2003
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:

Хайх хэрэгслүүд: